Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

News

14 April 2014

US congressional delegates review Cantab Mobile

Cantab Mobile has been highlighted to a US congressional delegation on ageing and healthcare policy as a breakthrough in enabling the earlier detection of dementia in primary care settings compared with existing assessments.

title

Cantab Mobile has been highlighted to a US congressional delegation on ageing and healthcare policy as a breakthrough in enabling the earlier detection of dementia in primary care settings compared with existing paper-based and other routine assessments.

The delegates visited the University of Cambridge in March and also the Department of Health to consider ways in which US and UK policymakers can work together to address the global challenges of ageing populations and dementia.  The visit was timed to build on the momentum generated at the recent G8 Dementia Summit in London (11 December 13) when UK Prime Minister David Cameron referenced the ‘extraordinary work’ of Cambridge Cognition.

Dr Andy Blackwell, CSO at Cambridge Cognition talked the US delegates through the patient, clinical and cost benefits of Cantab Mobile as part of a roundtable discussion on dementia research.  

The session was led by Barbara Sahakian, Professor of Clinical Neuropsychology and President of the British Association of Psychopharmacology who commented afterwards that the meetings were designed to: “further the aims of President Obama and Prime Minister Cameron in ensuring that people with dementia are detected early and receive the best possible treatments and management currently available”.